Home
About ISOP-Israel
The Advisory Board
How to be a member
Meetings
About ISOP
Annual meetings
Communication in congresses
Academic program
Working groups
Useful links
Contact us
News

ISoP 2013
1-4 October 2013, Pisa, Italy
Save money and register before 15 July! Abstracts submission is now closed

TOPRA - ISoP conference: Practical Application of Benefit-Risk Management
23 September 2013, Brussels, Belgium

ISoP Asia 2013 Symposium:
Singapore, 19-21 March 2013 (report)

ISoP 2012
30 Oct - 2 November 2012, Cancun, Mexico

ISoP GA Cancun - Thursday 1 November 2012: Cancun GA minutes are now available (with new elected ISoP Executive Committee and Officers)

20% discount on Oxford University Press for all ISoP members

Welcome to the South Eastern European Chapter!

ISoP Women's Medicines Group

ISoP is on LinkedIn (Members section)

The ENCePP Guide on Methodological Standards in Pharmacoepidemiology

EU Regulatory workshop on Medication Errors
28 February and 1 March 2013

Meeting report published on EMA website

20% discount on Wiley-Blackwell Pharmacology and Pharmaceutical Medicine books for all ISoP members

Drug Safety journal: issue Table of contents

 
https://static.wixstatic.com/media/61a761_76ff7aca760640ee8d3e531eb4c2864f~mv2.png/v1/fill/w_109,h_109,al_c,q_80,usm_0.66_1.00_0.01/Rina%20Fermont.webp

ד"ר אירן פרמונט מיסדת הסניף הישראלי בחברת ד"ר Hervé Le Louet נשיא ISOP במעמד החגיגי של הכרזת ישראל כחברה ב ISOP


The International Society of Pharmacovigilance, ISOP, has been created for sharing and spreading knowledge and expertise, especially through National/Regional Chapters.

The project of ISoP ISRAEL has started in January 2013 and was endorsed by the ISoP President and by the President of Tel Aviv University. Then the creation of the Israeli Chapter of ISoP was officially announced in October 2014 at the Annual Meeting in Tianjin (China).

Vision

ISoP ISRAEL has the mission to combine and utilize all existing strengths to improve pharmacovigilance and to raise it to the highest international standards to the benefit to all:

• The academia through research, developing tools and education
• The industry through identifying their needs and providing their experience
• The regulatory agency through the evaluation, framing and translation of all regulations

ISoP Israel chapter objectives are

  • Improve and harmonize pharmacovigilance systems in Israel
  • Increase awareness on patient’s safety
  • Gather all stakeholders
  • Be a think-tank
  • Support a mechanism for data sharing between all stakeholders and Ministry of Health
  • Use epidemiology tools for risk detection and to support the research and development of new tools and technologies

The Chapter will achieve this goal through:

  • An educational program:
    • For healthcare professionals and general public
    • Integration of pharmacovigilance courses in medical, paramedical and pharmacist studies
    • Academic specialization course.
  • Exchange knowledge, technology and experience with other countries and regions through organization of workshops, symposium…
  • Concept papers proposing models and means
  • Organization of multi-disciplinary days for converging technologies.
  • ISoP ISRAEL has the ambition to foster a unique and original pharmacovigilance system which will be shared with the international community.

Israel can rely on unique strengths and skills which must unite and share their results, especially:

  • Koupot Holim with their comprehensive and large epidemiologic databases
  • Risk Management Departments in the hospitals

ISOP ISRAEL has the ambition to foster a unique and original Pharmacovigilance system which will be shared with the international community.
Anyone interested in joining ISoP ISRAEL is invited to contact Dr Irene Fermont, ISOP ISRAEL Chairman irenefermont.isopisrael@gmail.com

CURRENT ACTIVITIES  

ISOP ISRAEL is focused on training and education. 3 tracks are currently set up in parallel:

  • SYMPOSIUM: 360°of DRUG SAFETY ; an international, multidisciplinary and solution-oriented 2-days conference : prevention of medication error , risk communication, patients’ empowerment, and a case study on anticoagulants  3-4 June Hotel Daniel, Herzliya
      
  • Integrated Risk management strategy to decrease the risk of anticoagulants: implemented in Maayanei Hayeshua Medical Centre;  built on the combination of several tools and methods such as ISMP® Safe Practices Self-Assessment of antithrombotic therapy
  • National Campaign to decrease the risk of anticoagulants in SuperPharm: an extensive campaign to advise patients under anticoagulants to prevent medication error and promote safer use . In collaboration with PSI, The Pharmaceutical Society of Israel.  

All the ISOP ISRAEL activities are mentored both by its Advisory Board or the most renowned experts , and of Board of ISOP International . These projects have been presented in several  international conferences and published in the peer-review Journal.          

ISOP ISRAEL has the mission to combine and utilize all existing strengths to improve Pharmacovigilance and to raise it to the highest international standards to the benefit of all:

  • the academia through research, developing tools and education,
  • the industry through identifying their needs and providing their experience
  • the Regulatory bodies through the evaluation, framing and translation of all gain to regulations and force its applying

ISOP ISRAEL objectives are:

  • Improve and harmonize Pharmacovigilance systems in Israel
  • Increase awareness on patient’s safety
  • Gather all stakeholders
  • Be a think tank
  • Support a mechanism for data sharing between all stakeholders and Ministry of Health
  • Use Epidemiology tools for risk detection and support the research and development of new tools and technologies